Raymond James sets $60 price target on Avalyn Pharma
Raymond James analyst initiated coverage on Avalyn Pharma with a price target of $60.00 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.